0.9(top 33%)
Impact Factor
0.9(top 33%)
extended IF
30(top 13%)
H-Index
709
authors
1.2K
papers
6.6K
citations
1.8K
citing journals
6K
citing authors

Most Cited Articles of European Urology Supplements

TitleYearCitations
Outcome of GreenLight HPS 120-W Laser Therapy in Specific Patient Populations: Those in Retention, on Anticoagulants, and with Large Prostates (≥ 80ml)200876
Benign Prostatic Hyperplasia and Its Aetiologies200975
Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer200869
Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events200864
Nocturia: consequences for sleep and daytime activities andassociated risks200563
Techniques and Training with GreenLight HPS 120-W Laser Therapy of the Prostate: Position Paper200862
The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study200560
Potential Benefits of Muscarinic M3 Receptor Selectivity200255
The physiology of sleep and the impact of ageing200554
Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis201049
Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome200746
Staging and Staging Errors in Bladder Cancer201045
Ureteropelvic Junction Obstruction201244
Transurethral Resection of the Prostate200944
Ileal Conduit as the Standard for Urinary Diversion After Radical Cystectomy for Bladder Cancer201043
The Pharmacokinetic Profile of Tamsulosin Oral Controlled Absorption System (OCAS®)200541
Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO)200540
CLINICAL PROOF OF CONCEPT STUDY (BLOSSOM) SHOWS NOVEL β3 ADRENOCEPTOR AGONIST YM178 IS EFFECTIVE AND WELL TOLERATED IN THE TREATMENT OF SYMPTOMS OF OVERACTIVE BLADDER200839
Recurrence, Progression, and Follow-Up in Non–Muscle-Invasive Bladder Cancer200938
Obstructive Bladder Dysfunction: Morphological, Biochemical and Molecular Changes200237
Should We Investigate Prostatic Inflammation for the Management of Benign Prostatic Hyperplasia?200935
Improved Classification of Urinary Tract Infection: Future Considerations201634
Bladder Cancer: A Major Public Health Issue200832
Cytology and Urinary Markers for the Diagnosis of Bladder Cancer200931
Early Complications and Morbidity of Radical Cystectomy201030